PRIMARY HYPERPARATHYROIDISM (literature review)
https://doi.org/10.51523/2708-6011.2013-10-4-5
Abstract
Primary hyperparathyroidism is a common endocrine disorder in adults and asymptomatic hypercalcemia is its typical manifestation. Primary hyperparathyroidism is clinically symptomatic in younger patients who reveal signs of hypercalcemia, skeletal complications and/or nephrolithiasis. In most cases, primary hyperparathyroidism is caused by a solitary benign parathyroid adenoma, rarely by multiple adenomas. The involvement of all the four parathyroid glands, so-called parathyroid hyperplasia, occurs in approximately 10 % cases. Parathyroid carcinoma is exceedingly uncommon (less than 1 %). Surgery is the principal treatment method for most adult patients with primary hyperparathyroidism, apart from the cases associated with hereditary hypocalciuric hypercalcemia.
About the Author
A. D. Borsuk
Republican Research Centre for Radiation Medicine and Human Ecology, Gomel
Belarus
Belarus
References
1. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century / J. P. Bilezikian [et al.] // J. Bone Miner. Res. - 2002. - Vol. 17, № 2. - P. 2-11.
2. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease / R. A. Wermers [et al.] // J. Bone Miner. Res. - 2006. - Vol. 21, № 1. - P. 171-177.
3. Melton, L. J. The rise and fall of primary hyperparathyroidism: a population based study in Rochester, Minnesota, 1965-1992 / L. J. Melton // Ann. Int. Med. - 1997. - Vol. 126, № 6. - P. 433-440.
4. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register / A. D. Morris [et al.] // Br. Med. J. - 1997. - Vol. 315. - P. 524-528.
5. Mortality and vascular outcomes in patients treated for thyroid dysfunction / R. W. Flynn [et al.] // J. Clin. Endocrinol. Metab. - 2006. - Vol. 91. - P. 2159-2164.
6. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK / N. Yu [et al.] // J. Clin. Endocrin. - 2009. - Vol. 71. - P. 485-493.
7. Epidemiology of Primary Hyperparathyroidism in Europe - report commissioned by Amgen / The Mattson Jack Group // Ref Type: Report. - 2003.
8. Primary hyperparathyroidism. An underdiagnosed disease in Denmark / M. Blichert-Toft [et al.] // Ugeskr. Laeger. - 1993. - Vol. 155. - P. 765-769.
9. Kaplan, E. L. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease / E. L. Kaplan, T. Yashiro, G. Salti // Ann. Surg. - 1992. - Vol. 215, № 4. - P. 300-317.
10. Khan, A. Primary hyperparathyroidism: pathophysiology and impact on bone / A. Khan, J. P. Bilezikian // Canad. Med. Assoc. Jorn. - 2000. - Vol. 163, № 2. - P. 184-187.
11. Clinical studies of multiple endocrine neoplasia type 1 (MENI) / D. Trump [et al.] // Q. J. Med. - 1996. - Vol. 89. - P. 653-669.
12. Beers, M. H. The Merck manual of diagnosis and therapy / M. H. Beers, R. Berkow // 17th ed. West Point, PA: Merck & Co Inc. - 1999.
13. Guidelines for diagnosis and therapy of MEN type 1 and type 2 / M. L. Brandi [et al.] // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86. - P. 5658-5681.
14. Long-term follow-up after parathyroidectomy for radiation-induced hyperparathyroidism / G. Ippolito [et al.] // Surgery. - 2007. - Vol. 142, № 6. - P. 819-822.
15. Dose-response relationships for radiation-induced hyperparathyroidism / A. B. Schneider [et al.] // J. Clin. Endocrinol. Metab. - 1995. - Vol. 80. - P. 254-257.
16. The American Association of clinical endocrinologists and The American Association of endocrine surgeons. Position statement on the diagnosis and management of primary hyperparathyroidism. Endocrine Practice. - 2005. - Vol. 11. - P. 49-54.
17. Burney, R. E. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels / R. E. Burney, K. R. Jones, B. Christy // Surgery. - 1999. - Vol. 125. - P. 608-614.
18. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey / G. B. Talpos [et al.] // Surgery. - 2000. - Vol. 128. - P. 1013-1020.
19. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study / A. K. Chan [et al.] // Ann. Surg. - 1995. - Vol. 222. - P. 402-414.
20. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge / O. H. Clark [et al.] // J. Bone Miner. Res. - 1991. - Vol. 6, № 2. - P. 135-142.
21. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up / T. Stefenelli [et al.] // J. Clin. Endocrinol. Metab. - 1997. - Vol. 82, № 1. - P. 106-112.
22. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial / E. Ambrogini [et al.] // Journal of Clinical Endocrinology & Metabolism. - 2007. - Vol. 92, № 8. - P. 3114-3121.
23. Bess, M. A. Hyperparathyroidism and pancreatitis. Chance or a causal association? / M. A. Bess, A. J. Edis, J. A. van Heerden // Journal of the American Medical Associations. - 1980. - Vol. 243. - P. 246-247.
24. Systematic Review of Primary Hyperparathyroidism in India: The Past, Present, and the Future Trends / P. V. Pradeep [et al.] // International Journal of Endocrinology. - 2011. - Vol. 2011. ID 921814, 7 pages.
25. Primary hyperparathyroidism in north India: a description of 52 cases / A. Bhansali [et al.] // Annals of Saudi Medicine. - 2005. - Vol. 25, № 1. - P. 29-35.
26. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years / M. R. Rubin [et al.] // J. Clin. Endocrinol. Metab. - 2008. - Vol. 93. - P. 3462-3470.
27. Makras, P. Medical treatment of hypercalcaemia / P. Makras, S. E. Papapoulos // Hormones. - 2009. - Vol. 8, № 2. - P. 83-95.
28. Gooding, A. W. Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions / A. W. Gooding, O. H. Clark // Am. J. Surg. - 1992. - Vol. 164. - P. 51-56.
29. Johnson, N. A. Parathyroid imaging: Technique and role in the preoperative evaluation of primary hyperparathyroidism / N. A. Johnson, M. E. Tublin, J. B. Ogilvie // AJR. - 2007. - Vol. 188. - P. 1706-1715.
30. Dimashkieh, H. Ultrasound guided fine needle aspiration biopsy of parathyroid glands and lesions / H. Dimashkieh, S. Krishnamurthy // Cytojournal. - 2006. - Vol. 3. - P. 6.
31. Черенько, С. М. Первичный гиперпаратиреоз: основы патогенеза, диагностики и хирургического лечения / С. М. Черенько. - Киев, 2011. - C. 148.
32. Tcm sestamibi - a new agent for parathyroid imaging / A. J. Coakley [et al.] // Nucl. Med. Commun. - 1989. - Vol. 10. - P. 791-794.
33. Randolph, G. W. Surgery of the thyroid and parathyroid glands / G. W. Randolph. - Philadelphia: Elsevier Science (USA), 2003. - P. 620.
34. The impact of Sestamibi scanning on the outcome of parathyroid surgery / J. Allendorf [et al.] // J. Clin. Endocrinol. Metab. - 2003. - Vol. 88. - P. 3015-3018.
35. Advantages of combined techneticum-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism / F. Lumachi [et al.] // European Journal of Endocrinology. - 2000. - Vol. 143. - P. 755-760.
36. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma / M. Haciyanli [et al.] // J. Am. Coll. Surg. - 2003. - Vol. 197. - P. 739-746.
37. Role of pre-operative imaging using (99m)Tc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy / D. Fuster [et al.] // Eur. J. Nucl. Med. Mol. Imaging. - 2006. - Vol. 33. - P. 467-473.
38. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands / E. T. Kasai [et al.] // Rev. Esp. Med. Nucl. - 2008. -Vol. 27. - P. 8-12.
39. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study / F. Lumachi [et al.] // BJR. - 2004. - Vol. 77. - P. 100-103.
40. Mihai, R. Imaging for primary hyperparathyroidism - an evidence-based analysis / R. Mihai, D. Simon, P. Hellman // Langenbeck’s Arch. Surg. - 2009. - Vol. 394. - P. 765-784.
41. Osamura, R. Y. Current practices in performing frozen sections for thyroid and parathyroid surgery / R. Y. Osamura, J. L. Hunt // Virchow Arch. - 2008. - Vol. 453. - P. 443-440.
42. Validation of a method to replace frozen section during parathyroid exploration by using the rapid parathyroid hormone assay on parathyroid aspirates / R. K. Chan [et al.] // Arch. Surg. - 2005. - Vol. 140. - P. 371-373.
43. Hedback, G. Death risk factor analysis in primary hyperparathyroidism / G. Hedback, A. Oden // Eur. J. Clin. Inv. - 1998. - Vol. 28. - P. 1011-1018.
44. Davies, M. Management of primary hyperparathyroidism / M. Davies, W. D. Fraser, D. J. Hosking // Clinical Endocrinology. - 2002. - Vol. 57. - P. 145-155.
Review
For citations:
Borsuk A.D. PRIMARY HYPERPARATHYROIDISM (literature review). Health and Ecology Issues. 2013;(4):33-40. (In Russ.) https://doi.org/10.51523/2708-6011.2013-10-4-5
Views: 243
Email this article 